Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Topiramate
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Recipient : University of Copenhagen
Deal Size : Inapplicable
Deal Type : Inapplicable
Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 20, 2014
Lead Product(s) : Topiramate
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Recipient : University of Copenhagen
Deal Size : Inapplicable
Deal Type : Inapplicable